BioVoice News May 2017 Issue 12 Volume 1 | Page 11

Taslimarif Saiyed is the Director and COO of Centre for Cellular and Molecular Platforms (C-CAMP). In this role, he manages C-CAMP’s technology platforms, growth strategies, strategic collaborations for new technology creation, education and training programmes, business and innovation accelerator unit. He also oversees the Intellecutual Property and Technology Transfer Office at C-CAMP. Prior to joining C-CAMP, he worked as a Scientist with University of California, San Francisco (UCSF), studying neurodegenerative diseases like Parkinson’s disease. He holds a doctorate in Neuroscience from Max-Planck Institute for Brain Research, Germany. In the bay area, he also served as a Management Consultant with QB3 New Biotech Venture Consulting as well as in an individual capacity where he consulted for biotech firms in the US. C-CAMP to do the early stage seed funding. Our strength is that we are driven by technology based startups. Idea is to identify the technologies t